Pamela L Kunz

9PUBLICATIONS
42CO-AUTHORS
Molecular targetsPharmacogenomicsPredictive and prognostic markersPharmaceutical delivery technologiesOncology and carcinogenesis not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 01, 2026
MET expression by immunohistochemistry as a biomarker in pancreatic neuroendocrine tumours.

|Jun 09, 2026
Dihydropyrimidine Dehydrogenase Testing: From Pharmacogenomics to Equitable Practice.

|Jan 09, 2026
Clinical Trial Patient Matching: A Real-Time, Common Data Model and Artificial Intelligence-Driven System for Semiautomated Patient Prescreening in Cancer Clinical Trials.

Guannan Gong, Jessica Liu, Sameer Pandya

|May 31, 2023
Consensus report of the 2021 National Cancer Institute neuroendocrine tumor clinical trials planning meeting.

Simron Singh, Thomas A Hope, Emily B Bergsland

|Dec 11, 2022
PRESTO 2: An International Survey to Evaluate Patients' Injection Experiences with the Latest Devices/Formulations of Long-Acting Somatostatin Analog Therapies for Neuroendocrine Tumors or Acromegaly.

Dermot O'Toole, Pamela L Kunz, Susan M Webb

|Sep 27, 2022
Exploratory genomic analysis of high-grade neuroendocrine neoplasms across diverse primary sites.

Thomas Yang Sun, Lan Zhao, Paul Van Hummelen

Pageof 2

Frequent Collaborators

2 joint publications

Ally Prebtani

2 joint publications

Antonio Ribeiro-Oliveira

2 joint publications

Dermot O'Toole

2 joint publications

Susan M Webb